These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3062806)

  • 21. [Clinical experience with ambroxol syrup (author's transl)].
    Göbel P; Rensch H
    Arzneimittelforschung; 1978; 28(5a):929-31. PubMed ID: 581992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term oral carbocisteine therapy in patients with chronic bronchitis. A double blind trial with placebo control.
    Grillage M; Barnard-Jones K
    Br J Clin Pract; 1985 Oct; 39(10):395-8. PubMed ID: 3907681
    [No Abstract]   [Full Text] [Related]  

  • 23. [New concepts in the therapy of mucostasis].
    von Seefeld H; Weiss JM; Rensch H
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():896-900. PubMed ID: 6689074
    [No Abstract]   [Full Text] [Related]  

  • 24. The pharmacology of ambroxol--review and new results.
    Disse BG
    Eur J Respir Dis Suppl; 1987; 153():255-62. PubMed ID: 3322865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo.
    Olivieri D; Zavattini G; Tomasini G; Daniotti S; Bonsignore G; Ferrara G; Carnimeo N; Chianese R; Catena E; Marcatili S
    Respiration; 1987; 51 Suppl 1():42-51. PubMed ID: 3299567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ambroxol decreases bronchial hyperreactivity.
    Melillo G; Cocco G
    Eur J Respir Dis; 1986 Nov; 69(5):316-20. PubMed ID: 3539631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normalization of bronchial exocrine pathology after endobronchial treatment with ambroxol.
    Aliperta A; Bellissimo U; Turco D; Antinolfi G
    Int J Tissue React; 1986; 8(2):167-74. PubMed ID: 2939036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of a clinical trial with ambroxol as to postoperative therapy of bronchitis (author's transl)].
    Kranicke R
    Arzneimittelforschung; 1978; 28(5a):934-5. PubMed ID: 581994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of fetal maturity indices in pregnancy with Rh isoimmunization treated with a preparation of Lasolvan].
    Woytoń J; Gabryś M; Regulska B; Szymczak J; Katnik I; Bielanow T
    Wiad Lek; 1986 Mar; 39(6):373-8. PubMed ID: 3088845
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect on the mucociliary clearance of ambroxol administered via inhalation: preliminary observations].
    Olivieri D; Del Donno M; Annicelli A; Palmieri F
    Arch Monaldi; 1983; 38(4):135-40. PubMed ID: 6679252
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of Lasolvan on the course of respiratory distress syndrome in newborn infants].
    Bajorek J; Czeszyńska M; Gizejowska M; Baryła-Pankiewicz E
    Pediatr Pol; 1987 Jun; 62(6):382-7. PubMed ID: 3670928
    [No Abstract]   [Full Text] [Related]  

  • 32. [The treatment of bronchitic syndrome using Transbronchin in the practice].
    Plietz J
    ZFA (Stuttgart); 1976 Dec; 52(35):1832-4. PubMed ID: 797159
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapeutic activity of ambroxol theophyllinacetate in chronic obstructive pulmonary diseases.
    Primbs K
    Clin Ther; 1985; 7(6):733-6. PubMed ID: 4075364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of ambroxol to influence the allergen induced bronchial constriction in sensitized guinea pigs.
    Becher G; Winsel K; Barleben A
    Biomed Biochim Acta; 1989; 48(8):589-92. PubMed ID: 2619729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional and clinical evaluation of feprazonebromhexine association in bronchopulmonary diseases.
    Del Bono N; Quartieri F; Renda B; Sconosciuto F; Vibelli C
    Panminerva Med; 1978; 20(2):117-22. PubMed ID: 360150
    [No Abstract]   [Full Text] [Related]  

  • 36. [Value of ambroxol in treatment of bronchial asthma and spastic bronchitis].
    Siergiejko Z; Obrzut D; Rogalewska A
    Pol Tyg Lek; 1991 May 27-Jun 3; 46(22-23):424-7. PubMed ID: 1669082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Changes in sputum in catarrhal bronchitis in children after treatment with S-carboxymethylcysteine (viscosimetric studies)].
    Castello D; Costa G; De Candussio G
    Minerva Pediatr; 1979 Mar; 31(5):371-80. PubMed ID: 460097
    [No Abstract]   [Full Text] [Related]  

  • 38. [Incorporation of a stimulant of the synthesis and secretion of pulmonary surfactant (ambroxol) in the medical treatment of serous otitis].
    Calero del Castillo JB; Pérez Martínez F; Piqueras Pérez F; Redondo Luciáñez ER
    An Otorrinolaringol Ibero Am; 1988; 15(2):209-18. PubMed ID: 3389499
    [No Abstract]   [Full Text] [Related]  

  • 39. The antenatal use of ambroxol (bromhexine metabolite VIII) to prevent hyaline membrane disease: a controlled double-blind study.
    Wauer RR; Schmalisch G; Menzel K; Schröder M; Müller K; Tiller R; Methfessel G; Sitka U; Koepke E; Plath C; Schlegel C; Böttcher M; Köppe I; Fricke U; Severin K; Jacobi R; Schmidt W; Hinkel GK; Nitz I; Kunze D; Reichmann G; Lachmann B; Lampe K; Grauel EL
    Int J Biol Res Pregnancy; 1982; 3(2):84-91. PubMed ID: 7042592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ambroxol for prophylaxis and treatment of bronchopulmonary complications after chest surgery.
    Romanini BM; Sandri MG; Tosi M; Mezzetti M; Mazzetti A
    Int J Clin Pharmacol Res; 1986; 6(2):123-7. PubMed ID: 3522443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.